Memantine for dementia
41 results
1 - 41
Memantine for dementia
Memantine for vascular dementia - Memantine for dementia in people with Down syndrome
- Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia
Memantine = placebo in patients with Down (MEADOWS)- Memantine for Alzheimer’s disease
- Dementia treatments minimally effective
- Continuing donepezil as dementia progresses is not helpful (DOMINO)
- Cognitive enhancers significantly improve Mini-Mental State Examination score in patients with Alzheimer's dementia
- Memantine for autism spectrum disorder
- Limited evidence for memantine in mild-moderate Alzheimer disease
- Pharmacological interventions for cognitive decline in people with Down syndrome
- Galantamine for Alzheimer’s disease
- Group cognitive stimulation therapy may improve quality of life in people with dementia
- Treatment of a patient with memory disease
- Some drugs slightly improve cognition in people with dementia; effects on behavioral or psychological symptoms remain unclear
- Limited amount and quality of data on medications for treating neuropsychiatric symptoms of dementia
- Italian guideline on diagnosing and managing dementia and mild cognitive impairment in adults
- Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting
- Vascular cognitive impairment (VCI)
- Antidepressants for agitation and psychosis in dementia
- Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation